Status:
COMPLETED
Continuous Versus Intermittent Oxytocin Infusion for Induction of Labor
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Induced; Birth
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The study will compare 2 treatment modalities. One group will receive the routine protocol of intermittent pitocin induction for 6 hours and the second group will receive continous pitocin infusion fo...
Detailed Description
After singing an informed consent, and prior to IOL initiation, study participants were randomly assigned (1:1) to receive either intermittent or continuous Oxytocin infusion. Both groups received the...
Eligibility Criteria
Inclusion
- Women with a singleton pregnancy that are admitted for induction or augmentation of labor.
- Women at gestational age 370/7 or more.
- Vertex presentation.
Exclusion
- Age under 18 or over 45.
- High order gestation.
- Women with contraindication for vaginal delivery.
- Active labor.
- Women with a uterine scar.
- Multiparity(\> 5 deliveries).
- Documented fetal anomalies.
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT04017247
Start Date
November 1 2019
End Date
June 30 2022
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam health care campus
Haifa, Israel